ID
NVAX icon

Integral Derivatives’s Novavax NVAX Stock Holding History

Integral Derivatives’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-860
Closed -$21K – 898
2017
Q4 		$21K Buy
+860
New +$21K ﹤0.01% 1090
2017
Q3 		– Sell
-640
Closed -$15K – 1252
2017
Q2 		$15K Sell
640
-35
-5% -$687 ﹤0.01% 1070
2017
Q1 		$17K Sell
675
-310
-31% -$8.53K ﹤0.01% 1118
2016
Q4 		$25K Buy
985
+295
+43% +$8.6K ﹤0.01% 1101
2016
Q3 		$29K Buy
+690
New +$89.1K ﹤0.01% 968

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return